Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104.
Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104
J Biol Chem. 2020 May 8;295(19):6721-6740. doi: 10.1074/jbc.RA120.012710. Epub 2020 Apr 2.
Protease-activated receptor 2 (PAR-2) is activated by secreted proteases from immune cells or fungi. PAR-2 is normally expressed basolaterally in differentiated nasal ciliated cells. We hypothesized that epithelial remodeling during diseases characterized by cilial loss and squamous metaplasia may alter PAR-2 polarization. Here, using a fluorescent arrestin assay, we confirmed that the common fungal airway pathogen activates heterologously-expressed PAR-2. Endogenous PAR-2 activation in submerged airway RPMI 2650 or NCI-H520 squamous cells increased intracellular calcium levels and granulocyte macrophage-colony-stimulating factor, tumor necrosis factor α, and interleukin (IL)-6 secretion. RPMI 2650 cells cultured at an air-liquid interface (ALI) responded to apically or basolaterally applied PAR-2 agonists. However, well-differentiated primary nasal epithelial ALIs responded only to basolateral PAR-2 stimulation, indicated by calcium elevation, increased cilia beat frequency, and increased fluid and cytokine secretion. We exposed primary cells to disease-related modifiers that alter epithelial morphology, including IL-13, cigarette smoke condensate, and retinoic acid deficiency, at concentrations and times that altered epithelial morphology without causing breakdown of the epithelial barrier to model early disease states. These altered primary cultures responded to both apical and basolateral PAR-2 stimulation. Imaging nasal polyps and control middle turbinate explants, we found that nasal polyps, but not turbinates, exhibit apical calcium responses to PAR-2 stimulation. However, isolated ciliated cells from both polyps and turbinates maintained basolateral PAR-2 polarization, suggesting that the calcium responses originated from nonciliated cells. Altered PAR-2 polarization in disease-remodeled epithelia may enhance apical responses and increase sensitivity to inhaled proteases.
蛋白酶激活受体 2(PAR-2)可被免疫细胞或真菌分泌的蛋白酶激活。PAR-2 通常在分化的鼻纤毛细胞的基底外侧表达。我们假设,在以纤毛丧失和鳞状化生为特征的疾病中,上皮重塑可能会改变 PAR-2 的极化。在这里,我们使用荧光抑制素测定法证实,常见的真菌性气道病原体可激活异源表达的 PAR-2。在浸没的气道 RPMI 2650 或 NCI-H520 鳞状细胞中,内源性 PAR-2 的激活增加了细胞内钙离子水平以及粒细胞-巨噬细胞集落刺激因子、肿瘤坏死因子-α和白细胞介素(IL)-6 的分泌。在气液界面(ALI)培养的 RPMI 2650 细胞对 PAR-2 激动剂的顶端或基底外侧应用均有反应。然而,分化良好的原代鼻上皮 ALI 仅对基底外侧 PAR-2 刺激有反应,表现为钙升高、纤毛摆动频率增加以及流体和细胞因子分泌增加。我们将疾病相关修饰剂(包括 IL-13、香烟烟雾冷凝物和维甲酸缺乏)暴露于原代细胞中,这些修饰剂的浓度和时间改变了上皮形态,但不会破坏上皮屏障,以模拟早期疾病状态。这些经修饰的原代培养物对顶端和基底外侧的 PAR-2 刺激均有反应。对鼻息肉和对照中鼻甲外植体进行成像,我们发现鼻息肉而非鼻甲对 PAR-2 刺激表现出顶端钙反应。然而,来自息肉和鼻甲的分离纤毛细胞均保持基底外侧 PAR-2 极化,这表明钙反应源自非纤毛细胞。疾病重塑的上皮中 PAR-2 极化的改变可能会增强顶端反应并增加对吸入蛋白酶的敏感性。